These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2371298)

  • 1. An industrial and UK perspective on short-term testing.
    Gatehouse DG
    Prog Clin Biol Res; 1990; 340D():249-59. PubMed ID: 2371298
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic toxicology testing requirements: official and unofficial views from Europe.
    Kirkland DJ
    Environ Mol Mutagen; 1993; 21(1):8-14; discussion 46-57. PubMed ID: 8419157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory requirement for three dose levels in rodent genetic toxicity assays.
    Galloway S
    Mutat Res; 1995 Jul; 329(2):213-9. PubMed ID: 7603503
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of the Gene-Tox Program.
    Auletta AE; Kier LD; Mitchell AD
    Prog Clin Biol Res; 1990; 340D():273-81. PubMed ID: 2371300
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precedents or possibilities: which should guide the harmonization of mutagenicity test protocols and carcinogen prediction strategies?
    Ashby J
    Mutat Res; 1993 Feb; 298(4):291-5. PubMed ID: 7678166
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on the US EPA recommendation for genotoxicity guidelines on chemicals.
    Ishidate M
    Mutat Res; 1992 Aug; 272(1):79-80. PubMed ID: 1380121
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies and testing methods for identifying mutagenic risks.
    MacGregor JT; Casciano D; Müller L
    Mutat Res; 2000 Nov; 455(1-2):3-20. PubMed ID: 11113464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH).
    Kamath GH; Rao KS
    Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of occupational carcinogens and mutagens.
    Ruder AM
    Occup Med; 1996; 11(3):487-512. PubMed ID: 8887381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese guidelines for mutagenicity testing. Ministry of Agriculture, Forestry and Fisheries; Ministry of Health and Welfare; Ministry of Labor.
    Sofuni T
    Environ Mol Mutagen; 1993; 21(1):2-7; discussion 46-57. PubMed ID: 8419152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of British Toxicology Society/UK Environmental Mutagen Society Working Group. Dose setting in in vivo mutagenicity assays.
    Fielder RJ; Allen JA; Boobis AR; Botham PA; Doe J; Esdaile DJ; Gatehouse DG; Hodson-Walker G; Morton DB; Kirkland DJ
    Mutagenesis; 1992 Sep; 7(5):313-9. PubMed ID: 1470025
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mammalian cell mutation assays in mutagenicity and carcinogenicity testing.
    Arlett CF; Cole J
    Mutagenesis; 1988 Nov; 3(6):455-8. PubMed ID: 3070282
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systematization of data and information on delayed consequences of the effects of chemicals in humans].
    Ianno LV; Pimenova MN; Osipova IV
    Med Tr Prom Ekol; 1993; (7-8):14-21. PubMed ID: 8038959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of short-term tests for carcinogenicity.
    Stoltz DR; Poirier LA; Irving CC; Stich HF; Weisburger JH; Grice HC
    Toxicol Appl Pharmacol; 1974 Aug; 29(2):157-80. PubMed ID: 4283682
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies for the identification of rodent carcinogens by in vitro short-term tests.
    Zeiger E
    Prog Clin Biol Res; 1990; 340D():261-71. PubMed ID: 2371299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estimation of genetic safety of nanomaterials].
    Sycheva LP; Zhurkov VS
    Vestn Ross Akad Med Nauk; 2011; (9):72-6. PubMed ID: 22145377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the UKEMS in the development of testing guidelines.
    Kirkland DJ
    Mutagenesis; 2002 Nov; 17(6):451-5. PubMed ID: 12435841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.